kleintier konkret, Table of Contents kleintier konkret 2017; 20(04): 10-16DOI: 10.1055/s-0043-104428 hund gynäkologie Enke Verlag in Georg Thieme Verlag KG StuttgartMammatumoren beim Hund – Teil 1: Ein Überblick über Risikofaktoren und die histologische Klassifikation Authors Author Affiliations Dorothee Krastel Fachtierärztin für Kleintiere, Tierarztpraxis Gommern Recommend Article Abstract Buy Article(opens in new window) All articles of this category(opens in new window) Mammatumore gehören zu den häufigsten Tumorerkrankungen der Hündin. Der 1. Teil des Beitrags gibt einen Überblick über mögliche Risikofaktoren und die Histologie des Tumors. In diesem Zusammenhang werden unter anderem der Einfluss der Frühkastration auf das Risiko der Entstehung von Mammatumoren und anderen Tumoren bei der Hündin diskutiert. Full Text References Literatur 1 Beauvais W, Cardwell JM, Brodbelt DC. The effect of neutering on the risk of mammary tumours in dogs – a systematic review. J Small Anim Pract 2012; 53 (6): 314-322 2 Benjamin SA, Lee AC, Saunders WJ. Classification and behavior of canine mammary epithelial neoplasms based on life-span observations in beagles. Vet Pathol 1999; 36 (5): 423-436 3 Brodey R, Goldschmidt J, Roszel J. Canine mammary gland neoplasms. J Am Anim Hosp Assoc 1983; 19: 61-90 4 Bruenger FW, Lloyd RD, Miller SC. et al. Occurrence of mammary tumors in beagles given radium-226. Radiat Res 1994; 138 (3): 423-434 5 Chang CC, Tsai MH, Liao JW. et al. Evaluation of hormone receptor expression for use in predicting survival of female dogs with malignant mammary gland tumors. J Am Vet Med Assoc 2009; 235 (4): 391-396 6 Chang SC, Chang CC, Chang TJ. et al. Prognostic factors associated with survival two years after surgery in dogs with malignant mammary tumors: 79 cases (1998–2002). J Am Vet Med Assoc 2005; 227 (10): 1625-1629 7 Clemente M, Pérez-Alenza MD, Illera JC. et al. Histological, immunohistological, and ultrastructural description of vasculogenic mimicry in canine mammary cancer. Vet Pathol 2010; 47 (2): 265-274 8 Concannon PW, Spraker TR, Casey HW. et al. Gross and histopathologic effects of medroxyprogesterone acetate and progesterone on the mammary glands of adult beagle bitches. Fertil Steril 1981; 36 (3): 373-387 9 Cooley DM, Beranek BC, Schlittler DL. et al. Endogenous gonadal hormone exposure and bone sarcoma risk. Cancer Epidemiol Biomarkers Prev 2002; 11 (11): 1434-1440 10 Dobson JM, Samuel S, Milstein H. et al. Canine neoplasia in the UK: estimates of incidence rates from a population of insured dogs. J Small Anim Pract 2002; 43 (6): 240-246 11 Dorn CR, Taylor DO, Schneider R. et al. Survey of animal neoplasms in Alameda and Contra Costa Counties, California. II. Cancer morbidity in dogs and cats from Alameda County. J Natl Cancer Inst 1968; 40 (2): 307-318 12 Egenvall A, Bonnett BN, Ohagen P. et al. Incidence of and survival after mammary tumors in a population of over 80000 insured female dogs in Sweden from 1995 to 2002. Prev Vet Med 2005; 69 (1–2): 109-127 13 Enginler SO, Akis I, Toydemir TS. et al. Genetic variations of BRCA1 and BRCA2 genes in dogs with mammary tumours. Vet Res Commun 2014; 38 (1): 21-27 14 Goldschmidt M, Pena L, Rasotto R. et al. Classification and grading of canine mammary tumors. Vet Pathol 2011; 48 (1): 117-131 15 Goldschmidt M, Shofer FS, Smelstoys JA. Neoplastic lesions of the mammary gland. In: Mohr U, Carlton WW, Dungworth DL. eds. Pathobiology of the Aging Dog. Ames, Iowa: Iowa State University Press; 2001 16 Gottwald D. Ein Beitrag zur Häufigkeit von Mammatumoren beim Hund. Statistische Auswertung der Einsendungen einer Praxis für Tierpathologie aus den Jahren 1990 bis 1995 München: Ludwig-Maximilians-Universität München; 1998 17 Healthcare Improvement Scotland. SIGN 50: A guideline developer’s handbook. Im Internet: http://www.sign.ac.uk/guidelines/fulltext/50/ Stand: April 2017 18 Im KS, Kim NH, Lim HY. et al. Analysis of a new histological and molecular-based classification of canine mammary neoplasia. Vet Pathol 2014; 51 (3): 549-559 19 Im KS, Kim IH, Kim NH. et al. Breed-related differences in altered BRCA1 expression, phenotype and subtype in malignant canine mammary tumors. Vet J 2013; 195 (3): 366-372 20 Martin de las Mulas J, Ordás J, Millán MY. et al. Immunohistochemical expression of estrogen receptor beta in normal and tumoral canine mammary glands. Vet Pathol 2004; 41 (3): 269-272 21 Millanta F, Calandrella M, Bari G. et al. Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues. Res Vet Sci 2005; 79 (3): 225-232 22 Misdorp W. Tumors of the mammary gland. In: Meuten DJ. ed. Tumors in Domestic Animals. 5th . ed. Hoboken, New Jersey: John Wiley & Sons; 2016 23 Misdorp W. Canine mammary tumours: protective effect of late ovariectomy and stimulating effect of progestins. Vet Q 1988; 10 (1): 26-33 24 Misdorp W, Hart AA. Prognostic factors in canine mammary cancer. J Natl Cancer Inst 1976; 56 (4): 779-786 25 Moe L. Population-based incidence of mammary tumours in some dog breeds. J Reprod Fertil Suppl 2001; 57: 439-443 26 Nieto A, Pena L, Pérez-Alenza MD. et al. Immunohistologic detection of estrogen receptor alpha in canine mammary tumors: clinical and pathologic associations and prognostic significance. Vet Pathol 2000; 37 (3): 239-247 27 Pena L, De Andrés PJ, Clemente M. et al. Prognostic value of histological grading in noninflammatory canine mammary carcinomas in a prospective study with two-year follow-up: relationship with clinical and histological characteristics. Vet Pathol 2013; 50 (1): 94-105 28 Pena L, Perez-Alenza MD, Rodriguez-Bertos A. et al. Canine inflammatory mammary carcinoma: histopathology, immunohistochemistry and clinical implications of 21 cases. Breast Cancer Res Treat 2003; 78 (2): 141-148 29 Pérez AD, Pena L, del Castillo N. et al. Factors influencing the incidence and prognosis of canine mammary tumours. J Small Anim Pract 2000; 41 (7): 287-291 30 Pérez AD, Rutteman GR, Pena L. et al. Relation between habitual diet and canine mammary tumors in a case-control study. J Vet Intern Med 1998; 12 (3): 132-139 31 Qiu HB, Sun WD, Yang X. et al. Promoter mutation and reduced expression of BRCA1 in canine mammary tumors. Res Vet Sci 2015; 103: 143-148 32 Richards HG, McNeil PE, Thompson H. et al. An epidemiological analysis of a canine-biopsies database compiled by a diagnostic histopathology service. Prev Vet Med 2001; 51 (1–2): 125-136 33 Rivera P, Melin M, Biagi T. et al. Mammary tumor development in dogs is associated with BRCA1 and BRCA2. Cancer Res 2009; 69 (22): 8770-8774 34 Schafer KA, Kelly G, Schrader R. et al. A canine model of familial mammary gland neoplasia. Vet Pathol 1998; 35 (3): 168-177 35 Schneider R. Comparison of age, sex, and incidence rates in human and canine breast cancer. Cancer 1970; 26 (2): 419-426 36 Schneider R, Dorn CR, Taylor DO. Factors influencing canine mammary cancer development and postsurgical survival. J Natl Cancer Inst 1969; 43 (6): 1249-1261 37 Sonnenschein EG, Glickman LT, Goldschmidt MH. et al. Body conformation, diet, and risk of breast cancer in pet dogs: a case-control study. Am J Epidemiol 1991; 133 (7): 694-703 38 Sorenmo K. Canine mammary gland tumors. Vet Clin North Am Small Anim Pract 2003; 33 (3): 573-596 39 Sorenmo KU, Kristiansen VM, Cofone MA. et al. Canine mammary gland tumours; a histological continuum from benign to malignant; clinical and histopathological evidence. Vet Comp Oncol 2009; 7 (3): 162-172 40 Stovring M, Moe L, Glattre E. A population-based case-control study of canine mammary tumours and clinical use of medroxyprogesterone acetate. APMIS 1997; 105 (8): 590-596 41 Stratmann N, Failing K, Richter A. et al. Mammary tumor recurrence in bitches after regional mastectomy. Vet Surg 2008; 37 (1): 82-86 42 Szczubial M, Lopuszynski W. Prognostic value of regional lymph node status in canine mammary carcinomas. Vet Comp Oncol 2011; 9 (4): 296-303 43 Taylor GN, Shabestari L, Williams J. et al. Mammary neoplasia in a closed beagle colony. Cancer Res 1976; 36 (8): 2740-2743 44 Torres de la Riva G, Hart BL, Farver TB. et al. Neutering dogs: effects on joint disorders and cancers in golden retrievers. PLoS One 2013; 8 (2): e55937 45 Tran CM, Moore AS, Frimberger AE. Surgical treatment of mammary carcinomas in dogs with or without postoperative chemotherapy. Vet Comp Oncol 2016; 14 (3): 252-262 46 Vascellari M, Capello K, Carminato A. et al. Incidence of mammary tumors in the canine population living in the Veneto region (Northeastern Italy): Risk factors and similarities to human breast cancer. Prev Vet Med 2016; 126: 183-189 47 Villamil JA, Henry CJ, Hahn AW. et al. Hormonal and sex impact on the epidemiology of canine lymphoma. J Cancer Epidemiol 2009; 2009: 591753 48 Ware WA, Hopper DL. Cardiac tumors in dogs: 1982–1995. J Vet Intern Med 1999; 13 (2): 95-103 49 White CR, Hohenhaus AE, Kelsey J. et al. Cutaneous MCTs: associations with spay/neuter status, breed, body size, and phylogenetic cluster. J Am Anim Hosp Assoc 2011; 47 (3): 210-216 50 Yamagami T, Kobayashi T, Takahashi K. et al. Prognosis for canine malignant mammary tumors based on TNM and histologic classification. J Vet Med Sci 1996; 58 (11): 1079-1083